Xilio Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Xilio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Xilio Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xilio Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $59 | 75 | 0.79 |
| 2024-06-30 | $56 | 59 | 0.95 |
| 2024-03-31 | $3.0k | 2.7k | 1.08 |
| 2023-12-31 | $1.6k | 2.9k | 0.55 |
| 2023-09-30 | $5.7k | 2.7k | 2.11 |
| 2023-06-30 | $7.1k | 2.7k | 2.62 |
| 2023-03-31 | $9.0k | 2.7k | 3.33 |
| 2022-12-31 | $7.0k | 2.7k | 2.59 |
| 2022-06-30 | $8.0k | 2.7k | 2.93 |
| 2022-03-31 | $35k | 4.8k | 7.15 |
| 2021-12-31 | $187k | 12k | 16.04 |